Belgium's Solvay sells its pharmaceutical business to Abbott Laboratories of US for $7.6 blnSeptember 30th, 2009 Solvay sells pharma division to Abbott for $7.6BBRUSSELS — Solvay, the Belgian chemical and pharmaceutical group, said Monday it has agreed to sell its entire pharmaceutical business to Abbott Laboratories of Abbott Park, Illinois, for euro5.2 billion ($7.6 billion). The American company already holds U.S.
Copart fiscal fourth-quarter profit falls 15 percent as sales slide more than 10 percentSeptember 23rd, 2009 Copart 4Q profit falls 15 percent on sales slideFAIRFIELD, Calif. — Copart Inc., a junk-car auction service, said Wednesday that its fiscal fourth-quarter profit fell 15 percent to $34.6 million, as sales fell more than 10 percent.
Cruise liner Carnival tops forecasts for 3Q despite 20 percent profit declineSeptember 22nd, 2009 Carnival profit falls 20 pct, still beats StreetCHICAGO — Carnival Corp. said Tuesday that its third-quarter profit fell nearly 20 percent, but the results were still better than expected as fuel prices fell and more travelers booked cruises.
Russian oil major Lukoil's net profit falls 44 percent in Q2 but beats analyst estimatesAugust 28th, 2009 Lukoil's Q2 net profit down 44 percentMOSCOW — Lukoil, Russia's largest private oil company, on Friday posted a 44 percent drop in net profit for the second quarter due to lower oil prices, but still beat analyst expectations. Net income fell to $2.3 billion from $4.1 billion a year earlier, the company said in a statement.
Williams-Sonoma profit drops on charges; raises outlook, citing improved sales trendAugust 26th, 2009 Williams-Sonoma 2Q profit falls partly on chargesSAN FRANCISCO — Williams-Sonoma Inc. said Wednesday that its profit tumbled in the second quarter on charges related to underperforming stores and lower sales.
Target's 2nd-quarter profits fall 6.2 pct, but results well exceed estimates amid cost-cuttingAugust 18th, 2009 Target's 2Q profit falls 6.2 pct, beats estimatesNEW YORK — Target says its second-quarter profit fell 6.3 percent, but results surpassed Wall Street forecasts amid cost-cutting initiatives and improvements in its credit-card business. The Minneapolis-based discounter says Tuesday that it earned $594 million, or 79 cents per share, in the period.
Abbott Laboratories pays $130 million to purchase nutrition unit in India, building its marketJuly 28th, 2009 Abbott pays $130 million to expand nutrition unitNORTH CHICAGO, Ill. — Abbott Laboratories said Tuesday it is expanding its nutritional business footprint in India with the $130 million buyout of a Wockhardt Ltd.
Actuate 2Q profit falls as revenue declines nearly 15 percentJuly 27th, 2009 Actuate 2Q profit clipped as revenue falls 15 pctSAN MATEO, Calif. — Actuate Corp.
German drug, chemical maker Merck second quarter net profit falls 48 percent to euro109 millionJuly 24th, 2009 Merck Q2 net profit falls 48 percent to euro109 MFRANKFURT — German drug and chemical maker Merck KGaA said Friday its second quarter net profit fell 48 percent as higher research costs and one-time effects from the acquisition of Serono weighed on the bottom line. The Darmstadt-based company reported a net profit of euro108 million ($153 million) in the April-June period compared with euro207 million a year earlier.
Abbott Laboratories' 2nd-quarter profit falls on charges but lead drug regains sales momentumJuly 15th, 2009 Abbott profit dips on charges, generic competitionDrug developer and medical device maker Abbott Laboratories said Wednesday its second-quarter profit fell 3 percent on a mix of buyout charges and lower drug sales, but the results still met Wall Street forecasts. Pharmaceutical sales fell 4.3 percent as the company's anti-seizure drug Depakote lost market share to generic competition.
Appeals court tosses antitrust claims lodged against Abbott Labs over AIDS drug costJuly 8th, 2009 Appeals court rules for Abbott in AIDS drug caseSAN FRANCISCO — A federal appeals court has rejected a lawsuit accusing Abbott Laboratories of antitrust violations over a sudden 400-percent price hike of a popular AIDS drug. Advocacy groups and drug benefit providers sued Abbott in 2004.
Nasdaq OMX Group's 1st-quarter profit falls to $94M, operating profit beats estimatesMay 8th, 2009 Nasdaq OMX Group 1Q profit slides 22 percentNEW YORK — Stock exchange operator Nasdaq OMX Group says its first-quarter profit fell 22 percent compared with the year-ago quarter when it booked hefty foreign exchange contract gains. The global exchange operator said Thursday it earned $94 million, or 44 cents per share, in the three months ended March 31.
Starbucks 2Q profit falls 77 percent on restructuring, but adjusted earnings beat estimatesApril 29th, 2009 Starbucks 2Q profit drops 77 percentSEATTLE — Starbucks says its fiscal second-quarter profit dropped 77 percent because of big restructuring charges related to closing more than 120 cafes. Seattle-based Starbucks Corp.
EMC 1Q profit drops 23 percent on charges, weak data-storage spending; sales missApril 23rd, 2009 EMC 1Q profit drops 23 percent, sales missSAN FRANCISCO — EMC Corp. says first-quarter profit dropped 23 percent on restructuring charges and weakness in data-storage spending, an area that has been fairly resilient to the recession.
Altria Group 1st-quarter profit falls 76 percent on charges, higher interest expensesApril 22nd, 2009 Altria Group 1Q profit drops 76 percentRICHMOND, Va. — Altria Group, the owner of the nation's biggest cigarette maker, says its first-quarter profit fell 76 percent because of acquisition charges and higher interest expenses.
Loading ...